Comments
Loading...
Outlook Therapeutics (OTLK) Forecast
NewsEarningsOutlook Therapeutics (OTLK) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestOutlook Therapeutics (NASDAQ:OTLK) Stock Quotes, Forecast and News Summary
Outlook Therapeutics Stock (NASDAQ: OTLK) stock price, news, charts, stock research, profile.
Compare
EPS better than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS better than industry
FAQ
How do I buy Outlook Therapeutics (OTLK) stock?
You can purchase shares of Outlook Therapeutics (NASDAQ:OTLK) through any online brokerage.
Who are Outlook Therapeutics (OTLK) competitors?
Other companies in Outlook Therapeutics’s space includes: Innate Pharma (NASDAQ:IPHA), Skye Bioscience (NASDAQ:SKYE), Cabaletta Bio (NASDAQ:CABA), Invizyne Technologies (NASDAQ:IZTC) and Adverum Biotechnologies (NASDAQ:ADVM).
What is the forecast, or price target, for Outlook Therapeutics (OTLK) stock?
Outlook Therapeutics has a consensus price target of $21.95.
What is the current price for Outlook Therapeutics (OTLK)?
The stock price for Outlook Therapeutics (NASDAQ: OTLK) is $5.25 last updated November 21, 2024 at 1:28 PM EST.
Does Outlook Therapeutics (OTLK) pay a dividend?
There are no upcoming dividends for Outlook Therapeutics.
When is Outlook Therapeutics (NASDAQ:OTLK) reporting earnings?
Outlook Therapeutics’s Q1 earnings are confirmed for Wednesday, February 12, 2025.
Is Outlook Therapeutics (OTLK) going to split?
There is no upcoming split for Outlook Therapeutics.
What sector and industry does Outlook Therapeutics (OTLK) operate in?
Outlook Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.